Cargando…
Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID‐19
The broad immunomodulatory properties of human mesenchymal stem cells (MSCs) have allowed for wide application in regenerative medicine as well as immune/inflammatory diseases, including unmatched allogeneic use. The novel coronavirus disease COVID‐19 has unleashed a pandemic in record time accompan...
Autores principales: | Yen, B. Linju, Yen, Men‐Luh, Wang, Li‐Tzu, Liu, Ko‐Jiunn, Sytwu, Huey‐Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300965/ https://www.ncbi.nlm.nih.gov/pubmed/32526079 http://dx.doi.org/10.1002/sctm.20-0186 |
Ejemplares similares
-
Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells
por: Wang, Li‐Tzu, et al.
Publicado: (2021) -
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
por: Chen, Pei-Min, et al.
Publicado: (2011) -
Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials
por: Wang, Li-Tzu, et al.
Publicado: (2016) -
Three-Dimensional Spheroid Culture of Human Mesenchymal Stem Cells: Offering Therapeutic Advantages and In Vitro Glimpses of the In Vivo State
por: Yen, B Linju, et al.
Publicado: (2023) -
Multipotent Human Mesenchymal Stromal Cells Mediate Expansion of Myeloid-Derived Suppressor Cells via Hepatocyte Growth Factor/c-Met and STAT3
por: Yen, B. Linju, et al.
Publicado: (2013)